SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-13-021634
Filing Date
2013-04-12
Accepted
2013-04-12 17:24:50
Documents
8
Period of Report
2012-12-31
Effectiveness Date
2013-04-12

Document Format Files

Seq Description Document Type Size
1 PROXY STATEMENT v340451_def14a.htm DEF 14A 555050
2 GRAPHIC line.gif GRAPHIC 43
3 GRAPHIC logo_intercept.jpg GRAPHIC 5420
4 GRAPHIC sig_mpruzanski.jpg GRAPHIC 4012
5 GRAPHIC sig_barbara-duncan.jpg GRAPHIC 7363
6 GRAPHIC spacer.gif GRAPHIC 43
7 GRAPHIC v340451_pc1.jpg GRAPHIC 270816
8 GRAPHIC v340451_pc2.jpg GRAPHIC 260795
  Complete submission text file 0001144204-13-021634.txt   1312789
Mailing Address 18 Desbrosses Street New York NY 10013
Business Address 18 Desbrosses Street NEW YORK NY 10013 646-747-1000
INTERCEPT PHARMACEUTICALS INC (Filer) CIK: 0001270073 (see all company filings)

IRS No.: 223868459 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-35668 | Film No.: 13759441
SIC: 2834 Pharmaceutical Preparations